FranΓ§aisπ See the interactive version (live chart) β
| Investment | Value today | Gain |
|---|---|---|
| 1 years ago (2025) | $1,637 | +64% |
| 3 years ago (2023) | $1,376 | +38% |
| 5 years ago (2021) | $1,833 | +83% |
| 10 years ago (2016) | $4,516 | +352% |
| since 2004 | $17,589 | +1659% |
| Year | Year's return | $1,000 invested at year start β worth today |
|---|---|---|
| 2026 (YTD) | +16% | $1,163 (+16%) |
| 2025 | +41% | $1,637 (+64%) |
| 2024 | +29% | $2,118 (+112%) |
| 2023 | -35% | $1,376 (+38%) |
| 2022 | +42% | $1,947 (+95%) |
| 2021 | -6% | $1,833 (+83%) |
| 2020 | +141% | $4,415 (+341%) |
| 2019 | +21% | $5,350 (+435%) |
| 2018 | -28% | $3,863 (+286%) |
| 2017 | +105% | $7,922 (+692%) |
| 2016 | -43% | $4,516 (+352%) |
π See the analyst analysis of Halozyme β
$1000 invested in Halozyme 5 years ago would be worth $1,833 today, and $4,516 over 10 years (price return, excluding dividends).
Calendar-year returns β 2024: +29%. 2025: +41%. 2026: +16%. Full breakdown in the table above.
Over 10 years, Halozyme's average annual return (CAGR) is about 16% per year, and 13%/yr over 5 years.
Best year: 2020 (+141%). Worst year: 2016 (-43%).
It's proportional β just multiply. Over 5 years, $1,000 invested in Halozyme is worth $1,833, so $100 would be worth a tenth, $5,000 five times more, and $10,000 ten times more. Use the calculator at the top of the page for your exact amount and chosen year.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Past performance, no predictive value and not investment advice. Prices in $, excluding dividends. Data: Yahoo Finance.